On the mechanism of the hepatocarcinogenicity of peroxisome proliferators.
暂无分享,去创建一个
B Beije | C Ramel | V. Préat | K. Erixon | V Préat | B. Beije | C. Ramel | R Nilsson | K Erixon | R. Nilsson
[1] J. Ashby,et al. Use of an in vivo/in vitro rat liver DNA repair assay to predict the relative rodent hepatocarcinogenic potency of 3 new azo mutagens. , 1985, Carcinogenesis.
[2] A. Meister,et al. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). , 1979, The Journal of biological chemistry.
[3] R C Gupta,et al. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Ljungman. Pretreatment with UV light renders the chromatin in human fibroblasts more susceptible to the DNA-damaging agents bleomycin, gamma radiation and 8-methoxypsoralen. , 1989, Carcinogenesis.
[5] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[6] J Ashby,et al. An assessment of the in vivo rat hepatocyte DNA-repair assay. , 1985, Mutation research.
[7] K P Lee,et al. Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. , 1987, Experimental and molecular pathology.
[8] M. Roberfroid,et al. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis. , 1986, Japanese journal of cancer research : Gann.
[9] J. Ward,et al. Tumor-initiating and promoting activities of di(2-ethylhexyl) phthalate in vivo and in vitro. , 1986, Environmental health perspectives.
[10] P. Baudhuin,et al. Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat-liver tissue. , 1964, The Biochemical journal.
[11] J. Reddy,et al. Peroxisome proliferation and lipid peroxidation in rat liver. , 1986, Cancer research.
[12] R. Cattley,et al. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. , 1989, Cancer research.
[13] T. Smith-Oliver,et al. Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment. , 1988, Carcinogenesis.
[14] C. Elcombe,et al. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. , 1986, Carcinogenesis.
[15] R. Floyd,et al. Formation of 8-hydroxydeoxyguanosine, hydroxyl free radical adduct of DNA in granulocytes exposed to the tumor promoter, tetradecanoylphorbolacetate. , 1986, Biochemical and biophysical research communications.
[16] B. Ames,et al. Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.
[17] J. Reddy,et al. Analysis of peroxisome proliferator-induced preneoplastic and neoplastic lesions of rat liver for placental form of glutathione S-transferase and gamma-glutamyltranspeptidase. , 1986, Cancer research.
[18] N. Oleinick,et al. Gamma radiation as a probe of chromatin structure: damage to and repair of active chromatin in the metaphase chromosome. , 1984, Radiation research.
[19] G. Guilbault,et al. New substrates for the fluorometric determination of oxidative enzymes. , 1968, Analytical chemistry.
[20] J. Vamecq,et al. Implication of a peroxisomal enzyme in the catabolism of glutaryl-CoA. , 1984, The Biochemical journal.
[21] J. Vamecq,et al. The microsomal dicarboxylyl-CoA synthetase. , 1985, The Biochemical journal.
[22] W. W. Nichols,et al. Short-term tests for carcinogens and mutagens. , 1979, Mutation research.
[23] M. Rao,et al. Enhancement by Wy-14,643, a hepatic peroxisome proliferator, of diethylnitrosamine-initiated hepatic tumorigenesis in the rat. , 1978, British Journal of Cancer.
[24] D. Beer,et al. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. , 1986, Cancer research.
[25] M. Roberfroid,et al. Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis. , 1986, Carcinogenesis.
[26] B. Ames,et al. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[27] B. Lake,et al. Effect of prolonged administration of clofibric acid and di-(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. , 1987, Toxicology.
[28] J. Ashby,et al. A non-invasive micronucleus assay in the rat liver. , 1988, Mutation research.
[29] A. Ootsuyama,et al. Formation of 8-hydroxyguanine moiety in cellular DNA by agents producing oxygen radicals and evidence for its repair. , 1986, Carcinogenesis.
[30] R. Cattley,et al. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. , 1988, Cancer research.
[31] G. Dallner,et al. Effects of dietary di(2-ethylhexyl)phthalate on the structure and function of rat hepatocytes. , 1983, Biochimica et biophysica acta.
[32] H. Glauert,et al. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis. , 1989, Cancer letters.
[33] N. Oleinick,et al. The sensitivity of active and inactive chromatin to ionizing radiation-induced DNA strand breakage. , 1982, International journal of radiation biology and related studies in physics, chemistry, and medicine.
[34] M Tanaka,et al. The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. , 1985, Journal of biochemistry.
[35] H. Pitot,et al. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. , 1984, Cancer letters.
[36] W. Stott. Chemically induced proliferation of peroxisomes: implications for risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.
[37] Reddy Jk,et al. Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to Humans , 1983 .
[38] M. Rao,et al. Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabeling. , 1991, Mutation research.
[39] J. Reddy,et al. Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. , 1989, Cancer research.
[40] G. Dallner,et al. Isolation of peroxisomes from rat liver using sucrose and Percoll gradients. , 1981, Journal of biochemical and biophysical methods.
[41] J. Reddy,et al. Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.
[42] J. Reddy,et al. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced liver peroxisomes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Langley,et al. Effects of perfluoro-n-decanoic acid on the respiratory activity of isolated rat liver mitochondria. , 1990, Journal of toxicology and environmental health.
[44] J. Popp,et al. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin. , 1987, Cancer research.
[45] P. Baudhuin,et al. Tissue fractionation studies. 18. Resolution of mitochondrial fractions from rat liver into three distinct populations of cytoplasmic particles by means of density equilibration in various gradients. , 1964, The Biochemical journal.